USL255
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for USL255, covering 2014-05-07 to 2015-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures [Phase 3]